CClinicalTrials.gg
Sign In
CompletedNCT04947839Updated Sep 29, 2022

Novel Equation for Estimating Resting Energy Expenditure in Dialysis Patients

An observational study in Resting Energy Expenditure, Peritoneal Dialysis and Equation, sponsored by Peking University First Hospital. Completed at 2 sites in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-09-29.

Sponsored by Peking University First Hospital · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

The energy and nutrition states are closely associated with dialysis patients' complications and outcomes. To reach the energy balance target, we need the accurate resting energy expenditure level of patients. Traditional equations do not focus on and applicable to peritoneal dialysis patients, so we aim to develop and validate an equation for estimating resting energy expenditure in peritoneal patients.

02

Conditions studied

  • Resting Energy Expenditure
  • Peritoneal Dialysis
  • Equation
03

In context

Lead sponsor

Peking University First Hospital is the lead sponsor of 378 studies on the registry; 178 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All peritoneal dialysis patients meet the inclusion and exclusion criteria in a single center

Inclusion criteria

  • Peritoneal dialysis patients and hemodialysis patients
  • Dialysis length >3 months
  • >18 years old
  • Consented to participate in all aspects of the study

Exclusion criteria

Exclusion Criteria:

  • Acute complications to hospitalization 1 month prior to the study;
  • Acute or chronic infections, cancer, and other wasting diseases in the past year;
  • Thyroid dysfunction;
  • Acute onset of podagra; Musculoskeletal diseases;
  • Respiratory diseases (asthma, pleural effusion, pneumothorax, COPD);
  • History of hormonal drug use;
  • During pregnancy or lactation;
  • Can not maintain posture and complete the REE test.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
200 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Novel equation development

    Developed equation for estimating resting energy expenditure in peritoneal dialysis patients

    Time frame: March 18, 2021 to October 30, 2021

  2. Novel equation validation

    Validate the novel equation with resting energy expenditure obtained by indirect calorimetry (IC).

    Time frame: October 30, 2021 to December 30, 2021

07

Study locations

2 sites
  • Peking University First Hospital
    Beijing, Beijing 100034, China
  • Peking Haidian Hospital
    Beijing, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 29, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04947839
Lead sponsor
Peking University First Hospital
Responsible party
Dong Jie (Clinical Professor in Renal Division，Department of Medicine, Peking University First Hospital) — Principal investigator
First posted
Jul 1, 2021
Start date
Mar 18, 2021
Primary completion
Jun 28, 2022
Completion
Jul 8, 2022
Last update
Sep 29, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Peking University First Hospital

Start the discussion